Landmark study to evaluate rapid testing for drug-resistant infections

The Fleming Initiative has partnered with diagnostic firm Cepheid to launch TRACE-CPE, a two-and-a-half-year research study to improve testing for anti-microbial resistance.

More....

Other News

Blood protein signature can predict lung cancer risk years earlier

Researchers at UCL and the Francis Crick Institute have identified 14 proteins in the blood that can predict lung cancer risk more than five years before diagnosis.

MHRA and FDA announce liaison programme

The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) have today announced a new liaison programme, marking a significant step forward in strengthening the regulatory partnership between the UK...

Review confirms effectiveness of infectious diseases in pregnancy screening in the UK

A new UK-wide effectiveness review shows that the national NHS Infectious Diseases in Pregnancy Screening (IDPS) programmes have been highly effective in reducing the transmission of serious infections from mother to baby.

UKHSA publishes first Health Security Risk Assessment

The UK Health Security Agency (UKHSA) has published its first Health Security Risk Assessment (HSRA), a publication which characterises the most significant health security risks facing the UK over the next five years.

Features

COVER STORY: Transforming infection diagnosis: 20-minute bacterial vs. viral test

Beckman Coulter Diagnostics’ Access MeMed BV assay, a test that helps clinicians differentiate between bacterial and viral infections, is now approved under the IVDR.

Automated mass spectrometry arrives at SWLP

With the UK’s first cobas Mass Spec solution, Roche Diagnostics is promising a step change in advanced diagnostics.

Products

New LIAISON tuberculosis assay improves efficiency and productivity

Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.

Menarini introduces Coyote FlashDetect PCR device range

Menarini has added Coyote FlashDetect PCR to its range of diagnostic solutions. These scalable rapid PCR devices will enable users to gain high quality results within 35 minutes.

QIAGEN unveils QIAsymphony Connect at AMP 2025

QIAGEN has launched QIAsymphony Connect, the next generation of its widely adopted automated nucleic acid purification platform, at the 2025 AMP (Association for Molecular Pathology) annual meeting.

ProtonDx's Dragonfly evaluated for identifying hidden malaria cases

A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.

Latest Issues

Featured Supplier

Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei,...

Learn more »

Cookie Name	Purpose	Duration	Type	Classification
`__pip_consent`	Stores user's cookie consent choice to prevent re-prompting	180 days	Essential	Strictly Necessary
`__pip_advertising`	Prevents advertising modal from showing more than once per session	Session	Essential	Strictly Necessary
`__pip_registration`	Prevents registration modal from showing more than once per session	Session	Essential	Strictly Necessary
`.AspNetCore.Antiforgery.*`	Protects against cross-site request forgery (CSRF) attacks	Session	Essential	Strictly Necessary
`_GRECAPTCHA`	Verifies user is human to prevent automated form submissions	180 days	Essential	Strictly Necessary
`__cf_clearance`	Stores proof of Cloudflare challenge passed to avoid repeated challenges.	1 year	Essential	Strictly Necessary
`__ga*`	Google Analytics cookies for tracking user behavior	2 years	Analytics	Consent Required

Sponsors

Landmark study to evaluate rapid testing for drug-resistant infections

Other News

Blood protein signature can predict lung cancer risk years earlier

Blood protein signature can predict lung cancer risk years earlier

MHRA and FDA announce liaison programme

MHRA and FDA announce liaison programme

Review confirms effectiveness of infectious diseases in pregnancy screening in the UK

Review confirms effectiveness of infectious diseases in pregnancy screening in the UK

UKHSA publishes first Health Security Risk Assessment

UKHSA publishes first Health Security Risk Assessment

Features

COVER STORY: Transforming infection diagnosis: 20-minute bacterial vs. viral test

Automated mass spectrometry arrives at SWLP

Products

New LIAISON tuberculosis assay improves efficiency and productivity

Menarini introduces Coyote FlashDetect PCR device range

QIAGEN unveils QIAsymphony Connect at AMP 2025

ProtonDx's Dragonfly evaluated for identifying hidden malaria cases

Latest Issues

Featured Supplier

Upcoming Events

24th European Pathology Congress

Manchester Pathology 2026

UK NEQAS webinar: Introduction to Immunocytochemistry

UK NEQAS webinar: Introduction to Direct Immunofluorescence

IHC Antibody Recognition & Expression Master Class

Sponsors

Landmark study to evaluate rapid testing for drug-resistant infections

Blood protein signature can predict lung cancer risk years earlier

Blood protein signature can predict lung cancer risk years earlier

MHRA and FDA announce liaison programme

MHRA and FDA announce liaison programme

Review confirms effectiveness of infectious diseases in pregnancy screening in the UK

Review confirms effectiveness of infectious diseases in pregnancy screening in the UK

UKHSA publishes first Health Security Risk Assessment

UKHSA publishes first Health Security Risk Assessment

Latest Issues

Cookies on pathologyinpractice.com

More Details